MD952C2 - Способ лечения вторичной хронической плацентарной недостаточности - Google Patents

Способ лечения вторичной хронической плацентарной недостаточности

Info

Publication number
MD952C2
MD952C2 MD97-0003A MD970003A MD952C2 MD 952 C2 MD952 C2 MD 952C2 MD 970003 A MD970003 A MD 970003A MD 952 C2 MD952 C2 MD 952C2
Authority
MD
Moldova
Prior art keywords
treatment
placental insufficiency
chronic secondary
chronic
placental
Prior art date
Application number
MD97-0003A
Other languages
English (en)
Romanian (ro)
Other versions
MD952B1 (en
Inventor
Victor Artemiev
Людмила ЕЦКО
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MD97-0003A priority Critical patent/MD952C2/ru
Publication of MD952B1 publication Critical patent/MD952B1/xx
Publication of MD952C2 publication Critical patent/MD952C2/ru

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к медицине, а именно к акушерству.Сущность способа состоит в том, что беременным с вторичной хронической плацентарной недостаточностью в течение 30-35 дней вводят по 0,75-1,25 г splat перорально 2-3 раза в день, в суточной дозе 1,5-2,5 г.Техническим результатом предло-женного способа является норма-лизация белкового, липидного обмена и гормонопродуцирующей функции плаценты
MD97-0003A 1997-01-13 1997-01-13 Способ лечения вторичной хронической плацентарной недостаточности MD952C2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD97-0003A MD952C2 (ru) 1997-01-13 1997-01-13 Способ лечения вторичной хронической плацентарной недостаточности

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD97-0003A MD952C2 (ru) 1997-01-13 1997-01-13 Способ лечения вторичной хронической плацентарной недостаточности

Publications (2)

Publication Number Publication Date
MD952B1 MD952B1 (en) 1998-04-30
MD952C2 true MD952C2 (ru) 1998-12-31

Family

ID=19738943

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0003A MD952C2 (ru) 1997-01-13 1997-01-13 Способ лечения вторичной хронической плацентарной недостаточности

Country Status (1)

Country Link
MD (1) MD952C2 (ru)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Т.М. Савельева, М.В. Федорова, П.А. Клименко, Л.Т. Сичинова "Плацентарная недостаточность", 1991 г., "Медицина", Москва, с. 228-255. *

Also Published As

Publication number Publication date
MD952B1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
AU5653994A (en) Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries
CA2195093A1 (en) Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
GEP20022783B (en) Method of Preventing and Delaying Onset of Alzheimer's Disease and Composition Therefor
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
GEP20022630B (en) Progesterone for Treating or Reducing Ischemia
CA2245123A1 (fr) Extrait de rosacees en tant qu'antagoniste de bradykinine
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
CA2221255A1 (en) Use of selegiline to treat hearing loss in mammals
MD952C2 (ru) Способ лечения вторичной хронической плацентарной недостаточности
ZA967319B (en) Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
MX9500231A (es) Analgesicos de 4-arilsoindol.
CA2157590A1 (en) Use of terbinafine for the therapeutic treatment of pneumocystosis
PL336662A1 (en) Tissular factor producing a blood vesell formation effect
MD916G2 (ru) Мазь для лечения стоматологических заболеваний
WO1996028214A3 (en) Treatment of pulmonary hypertension with a bombesin antagonist
CA2192071A1 (en) Putamen ovi
AU5760596A (en) Component b as cicatrizant
IL123382A0 (en) Preparation for the prophylaxis and/or treatment of wool and hair loss
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
MX9803681A (es) Inhibicion de la expresion de membrana.
GEU1998402Y (en) Means for Treatment of Skin Cancer - “Khvedelidze Ointment”
AU7436098A (en) Use of mizolastine for preparing a medicine for treating inflammation
GEP19970715B (en) Anti-Inflammatory and Pail-Allaying Medicinal Means
AU1756299A (en) Use of putamen ovi

Legal Events

Date Code Title Description
FG4A Patent for invention issued
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20170113